Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US15518782Application Date: 2015-10-22
-
Publication No.: US09944596B2Publication Date: 2018-04-17
- Inventor: Yoshihiro Banno , Masahiro Kamaura , Takahiko Taniguchi , Kazuaki Takami , Koichiro Fukuda , Shigekazu Sasaki
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2014-217769 20141024
- International Application: PCT/JP2015/079783 WO 20151022
- International Announcement: WO2016/063934 WO 20160428
- Main IPC: C07D207/08
- IPC: C07D207/08 ; A61K31/401

Abstract:
Provided is a heterocyclic compound having a superior RBP4-lowering action and useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4. A compound represented by the formula (I): wherein each symbol is as defined in the Description, or a salt thereof has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of a disease or symptom mediated by an increase in RBP4 or retinol supplied by RBP4.
Public/Granted literature
- US20170233339A1 HETEROCYCLIC COMPOUND Public/Granted day:2017-08-17
Information query